Skip to main content
Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
168.62
+3.11 (1.88%)
At close: Feb 27, 2026, 4:00 PM EST
170.84
+2.22 (1.32%)
After-hours: Feb 27, 2026, 7:51 PM EST

Novartis AG Revenue

In the year 2025, Novartis AG had annual revenue of $56.67B with 9.57% growth. Novartis AG had revenue of $13.86B in the quarter ending December 31, 2025, with 2.23% growth.

Revenue (ttm)
$56.67B
Revenue Growth
+9.57%
P/S Ratio
5.71
Revenue / Employee
$752,973
Employees
75,267
Market Cap
323.85B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202556.67B4.95B9.57%
Dec 31, 202451.72B5.06B10.85%
Dec 31, 202346.66B3.20B7.36%
Dec 31, 202243.46B-513.00M-1.17%
Dec 31, 202143.97B-5.92B-11.87%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Johnson & Johnson 94.19B
Merck & Co. 65.01B
Pfizer 62.58B
AbbVie 61.16B
AstraZeneca 58.74B
Sanofi 54.85B
Novo Nordisk 48.59B
Bristol-Myers Squibb Company 48.19B
Revenue Rankings

NVS News

More News